Evidence map›Paper›PMID 33673272›Full record

ArticleMolecules (Basel, Switzerland)2021

Binding and Sensing Properties of a Hybrid Naphthalimide-Pyrene Aza-Cyclophane towards Nucleotides in an Aqueous Solution.

Aleksandr M Agafontsev, Aleksandr S Oshchepkov, Tatiana A Shumilova, Evgeny A Kataev

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Aleksandr M AgafontsevN. N. Vorozhtsov Institute of Organic Chemistry SB RAS, 9th Lavrentiev Avenue, 630090 Novosibirsk, Russia.
Aleksandr S OshchepkovInstitute of Chemistry, Technische Universität Chemnitz, 09107 Chemnitz, Germany.ORCID 0000-0002-1321-8485
Tatiana A ShumilovaInstitute of Chemistry, Technische Universität Chemnitz, 09107 Chemnitz, Germany.
Evgeny A KataevDepartment of Chemistry and Pharmacy, University of Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany.ORCID 0000-0003-4007-8489
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEChemnitz University of Technology · DENovosibirsk Institute of Organic Chemistry · RU

Funding

CSRD VA 1
6 · The paper itself

Abstract

Selective recognition of nucleotides with synthetic receptors is an emerging direction to solve a series of nucleic acid-related challenges in biochemistry. Towards this goal, a new aza-cyclophane with two different dyes, naphthalimide and pyrene, connected through a triamine linker has been synthesized and studied for the ability to bind and detect nucleoside triphosphates in an aqueous solution. The receptor shows Foerster resonance energy transfer (FRET) in fluorescence spectra upon excitation in DMSO, which is diminished dramatically in the presence of water. According to binding studies, the receptor has a preference to bind ATP (adenosine triphosphate) and CTP (cytidine triphosphate) with a "turn-on" fluorescence response. Two separate emission bands of dyes allow one to detect nucleotides in a ratiometric manner in a broad concentration range of 10

Indexed as

Adenosine TriphosphateCyclophanesEthers, CyclicFluorescent DyesHydrogen BondingMolecular StructureNaphthalimidesNucleotidesPiperidinesPyrenesSolutionsSpectrometry, FluorescenceWaterAdenosine Triphosphatecyclophane 1CyclophanesEthers, CyclicFluorescent DyesNaphthalimidesNucleotidesPiperidinespyrenePyrenesSolutionsWatercyclophanefluorescent probehost–guest chemistrynucleotide recognitionsupramolecular recognition

Identifiers

PMID33673272
PMCPMC7918853
OpenAlexW3131096876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.